{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:20:12Z","timestamp":1786994412304,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.msard.2023.104893","type":"journal-article","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T01:42:06Z","timestamp":1689471726000},"page":"104893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3819-9409","authenticated-orcid":false,"given":"P","family":"Valentino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Malucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CI","family":"Bava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Martire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Capobianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Malentacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Sperli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Oggero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Di Sapio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bertolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2023.104893_bib0001","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000555","article-title":"Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS","volume":"6","author":"Akg\u00fcn","year":"2019","journal-title":"Neurol. Neuroimmunol. NeuroInflammation"},{"key":"10.1016\/j.msard.2023.104893_bib0002","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/brain\/awy154","article-title":"Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis","volume":"141","author":"Barro","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.msard.2023.104893_bib0003","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/acn3.51234","article-title":"Blood neurofilament light: a critical review of its application to neurologic disease","volume":"7","author":"Barro","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2023.104893_bib0004","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2023.104893_bib0005","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"PML diagnostic criteria: consensus statement from the AAN neuroinfectious disease section","volume":"80","author":"Berger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104893_bib0006","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1093\/brain\/awab241","article-title":"The potential of serum neurofilament as biomarker for multiple sclerosis","volume":"144","author":"Bittner","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.msard.2023.104893_bib0007","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/ana.25437","article-title":"Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients","volume":"85","author":"Dalla Costa","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2023.104893_bib0008","doi-asserted-by":"crossref","first-page":"e1201","DOI":"10.1212\/WNL.0000000000009097","article-title":"Blood neurofilament light levels segregate treatment effects in multiple sclerosis","volume":"94","author":"Delcoigne","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104893_bib0009","article-title":"EMA confirms recommendations to minimise risk of brain infection PML with Tysabri [WWW Document]","year":"2016","journal-title":"Sci. Med. Heal."},{"key":"10.1016\/j.msard.2023.104893_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000001003","article-title":"Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab","volume":"8","author":"Fissolo","year":"2021","journal-title":"Neurol. Neuroimmunol. neuroinflammation"},{"key":"10.1016\/j.msard.2023.104893_bib0011","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/00365513.2020.1730434","article-title":"Reference interval and preanalytical properties of serum neurofilament light chain in Scandinavian adults","volume":"80","author":"Hviid","year":"2020","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.msard.2023.104893_bib0012","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1177\/13524585221108080","article-title":"No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab","volume":"28","author":"Johnsson","year":"2022","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2023.104893_bib0013","doi-asserted-by":"crossref","first-page":"P706","DOI":"10.1016\/j.jalz.2018.06.783","article-title":"P2-098: comparison of Two Platforms Quantitating Fg\/Ml Neurological Biomarkers Using Single Molecule Arrays and Digital Elisa: the Benchtop Reader Sr-X\u2122 and the Fully Automated Analyzer Hd-1\u2122","volume":"14","author":"Lambert","year":"2018","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.msard.2023.104893_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/brainsci10010056","article-title":"Neurofilaments: the C-reactive protein of neurology","volume":"10","author":"Lambertsen","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.msard.2023.104893_bib0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1212\/NXI.0000000000000599","article-title":"Blood neurofilament light chain at the doorstep of clinical application","volume":"6","author":"Leppert","year":"2019","journal-title":"Neurol. Neuroimmunol. NeuroInflammation"},{"key":"10.1016\/j.msard.2023.104893_bib0016","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ana.25523","article-title":"Serum neurofilaments as candidate biomarkers of natalizumab associated progressive multifocal leukoencephalopathy","volume":"86","author":"Loonstra","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2023.104893_bib0017","first-page":"43","article-title":"BB-cresm: a structured institutional biobank for quality research in multiple sclerosis_LB1245","volume":"26","author":"Marnetto","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2023.104893_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103995","article-title":"Use of natalizumab in persons with multiple sclerosis: 2022 update","volume":"65","author":"Morrow","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104893_bib0019","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/WNL.0000000000004683","article-title":"Monitoring disease activity in multiple sclerosis using serum neurofilament light protein","volume":"89","author":"Novakova","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104893_bib0020","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/1352458518786075","article-title":"Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients","volume":"25","author":"Oshima","year":"2019","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2023.104893_bib0021","doi-asserted-by":"crossref","unstructured":"Schwab, N., Schneider-, T., Melzer, N., Cutter, G., Wiendl, H., 2017. Natalizumab-associated PML.","DOI":"10.1212\/WNL.0000000000003739"},{"key":"10.1016\/j.msard.2023.104893_bib0022","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1352458509356368","article-title":"Short commentary on\u00a0?a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking?","volume":"16","author":"Teunissen","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104893_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-67504-6","article-title":"Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis","volume":"10","author":"Thebault","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2023.104893_bib0024","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2023.104893_bib0025","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000714","article-title":"Monitoring of radiologic disease activity by serum neurofilaments in MS","volume":"7","author":"Uher","year":"2020","journal-title":"Neurol. Neuroimmunol. neuroinflammation"},{"key":"10.1016\/j.msard.2023.104893_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104176","article-title":"sNFL applicability as additional monitoring tool in natalizumab extended interval dosing regimen for RRMS patients","volume":"67","author":"Valentino","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104893_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103090","article-title":"Serum neurofilament light chain levels in healthy individuals: a proposal of cut-off values for use in multiple sclerosis clinical practice","volume":"54","author":"Valentino","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104893_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00338","article-title":"Neurofilament light chain as a biomarker in multiple sclerosis","author":"Varhaug","year":"2019","journal-title":"Front. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823003942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823003942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T09:10:09Z","timestamp":1737623409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823003942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":28,"alternative-id":["S2211034823003942"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104893","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104893"}}